[
Abdel-Kader K. Unruh M.L. Weisbord S.D. (2009). Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol. 4: 1057-1064.
]Search in Google Scholar
[
Bitran JD, Desser RK, Billings AA, Kozloff MF, Shapiro CM. (1982). Acute nephrotoxicity following cis-dichlorodiammine-platinum. Cancer. 49:1784-1788.
]Search in Google Scholar
[
Bubis L.D. Davis L. Mahar A. et al. (2018). Symptom burden in the first Year after cancer Diagnosis: An Analysis of patient-Reported outcomes. J Clin Oncol. 36: 1103-1111.
]Search in Google Scholar
[
Crawford J. Cella D. Cleeland C.S. et al. (2002). Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer. 95: 888-895.
]Search in Google Scholar
[
Dai, L., Golembiewska, E., Lindholm, B., and Stenvinkel, P. (2017). End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes, in Expanded Hemodialysis: Innovative Clinical Approach in Dialysis, 32–43. doi:10.1159/000479254 .
]Search in Google Scholar
[
De Cavanagh, E. M. V., Piotrkowski, B., and Fraga, C. G. (2004). Concerted Action of the Renin-Angiotensin System, Mitochondria, and Antioxidant Defenses in Aging. Mol. Aspects Med. 25, 27–36. doi: 10.1016/j.mam.2004.02.006
]Search in Google Scholar
[
Ebert, T., Pawelzik, S.-C., Witasp, A., Arefin, S., Hobson, S., Kublickiene, K., et al. (2020). Inflammation and Premature Ageing in Chronic Kidney Disease. Toxins 12, 227. doi:10.3390/toxins12040227
]Search in Google Scholar
[
Garcia J.M. Li H. Mann D. et al. (2006). Hypogonadism in male patients with cancer. Cancer. 106: 2583-2591.
]Search in Google Scholar
[
Gelfand S.L. Schell J.O. Eneanya N.D. (2020). Palliative care in nephrology: the Work and the Workforce.Adv Chronic Kidney Dis. 27: 350-355.
]Search in Google Scholar
[
Gelfand S.L. Scherer J.S. Koncicki H.M. (2020). Kidney supportive care: Core Curriculum 2020. Am J Kidney Dis.75: 793-806.
]Search in Google Scholar
[
Inker L.A., Schmid C.H., Tighiouart H. (2012). Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 367:20–29.
]Search in Google Scholar
[
Jager K.J., Kovesdy C., Langham R., et al (2019). Asingle number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 96:1048–1050.
]Search in Google Scholar
[
Liu L., Zhu M., Meng Q. (2020). Association between kidney function and the risk of cancer: results from the China health and retirement longitudinal study (Charls) J Cancer. 11:6429–6436.
]Search in Google Scholar
[
Lees JS, Ho F, Parra-Soto S et al. (2021). Kidney function and cancer risk: an analysis using creatinine and cystatin C in a cohort study. EClinicalMedicine. 38: 101030.
]Search in Google Scholar
[
Masereeuw, R., Mutsaers, H. A. M., Toyohara, T., Abe, T., Jhawar, S., Sweet, D. H., et al. (2014). The Kidney and Uremic Toxin Removal: Glomerulus or Tubule? Seminars Nephrol.34, 191–208. doi:10.1016/j.semnephrol.2014.02.010.
]Search in Google Scholar
[
Mok Y, Matsushita K, Sang Y et al. (2016). Association of kidney disease measures with cause-specific mortality: the Korean Heart Study. PLoS One 11: e0153429.
]Search in Google Scholar
[
Mok Y., Ballew S.H., Sang Y. (2020). Albuminuria, kidney function, and cancer risk in the community. Am J Epidemiol.189:942–950.
]Search in Google Scholar
[
Paladino J. Lakin J.R. Sanders J.J. (2019). Communication strategies for sharing prognostic information with patients: beyond survival statistics. JAMA. 322: 1345-1346.
]Search in Google Scholar
[
Putri, A. Y., and Thaha, M. (2014). Role of Oxidative Stress on Chronic Kidney Disease Progression. Acta Med. Indones. 46, 244–252.
]Search in Google Scholar
[
Tarricone R. Ricca G. Nyanzi-Wakholi B. Medina-Lara A. (2016). Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilization: a systematic review. Crit Rev Oncol Hematol. 99: 49-62.
]Search in Google Scholar
[
Tu H, Wen CP, Tsai SP et al. (2018). Cancer risk associated with chronic diseases and disease markers: prospective cohort study. BMJ. 360: k134. doi: 10.1136/bmj.k134.
]Search in Google Scholar
[
Santos MLC, Brito BB, da Silva FAF, Botelho ACDS, Melo FF. (2020). Nephrotoxicity in cancer treatment: An overview. World J Clin Oncol. 11(4): 190-204.
]Search in Google Scholar
[
Sevilya, Z., Leitner-Dagan, Y., Pinchev, M., Kremer, R., Elinger, D., Rennert, H. S., et al. (2014). Low Integrated DNA Repair Score and Lung Cancer Risk. Cancer Prev. Res. 7, 398–406. doi: 10.1158/1940-6207.CAPR-13-0318.
]Search in Google Scholar
[
Weng PH, Hung KY, Huang HL et al. (2011). Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol. 6: 1121–1128.
]Search in Google Scholar
